News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Japan Approves AstraZeneca PLC’s (JOBS) Symbicort
October 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Drugmaker AstraZeneca PLC said Friday that its Symbicort inhaler has been approved in Japan for use as a treatment for asthma in adults.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Approvals
J&J Steps Into Crowded Myasthenia Gravis Market With FDA Nod
May 1, 2025
·
2 min read
·
Tristan Manalac
Government
FDA Misses Another Deadline Amid Staff Exodus, Structural Disruptions
May 1, 2025
·
2 min read
·
Tristan Manalac
Podcast
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
April 30, 2025
·
1 min read
·
Heather McKenzie
Rare diseases
Abeona Gets FDA Nod for Rare Skin Disease Gene Therapy
April 29, 2025
·
1 min read
·
Dan Samorodnitsky
